Clinical Trials Logo

Filter by:
NCT ID: NCT04262752 Completed - Constipation Clinical Trials

MOWOOT Device to Treat Constipation in Adults

Start date: January 11, 2018
Phase: N/A
Study type: Interventional

The aim was to assess the safety and effectiveness of the automatic colon-specific massage with the MOWOOT device for patients suffering from chronic constipation due to Multiple Sclerosis, Parkinson Disease (NBD) or other unknown causes (Idiopathic).The hypothesis is that this treatment administered daily in home-use settings could ameliorate constipation in chronically affected people.

NCT ID: NCT04262271 Completed - Respiratory Disease Clinical Trials

A Study to Identify Errors in Inhaler Technique in Adults

SCORES
Start date: August 7, 2019
Phase:
Study type: Observational

This study will observe the inhaler technique of people using 13 different inhaler types; record any technique errors being made against checklists developed for each inhaler device based on their manufacturer's guidelines, and reeducate any observed inhaler technique errors as required.

NCT ID: NCT04260815 Completed - Stroke Clinical Trials

The Effect of Non-invasive Brian Stimulation on Language Production in Healthy Older Adults

Start date: October 2, 2018
Phase: N/A
Study type: Interventional

The use of non-invasive brain stimulation techniques like transcranial direct-current stimulation (tDCS) for rehabilitation of language is a growing field that needs further studies to determine how best it can be used to enhance treatment outcomes. It has been shown that tDCS can improve language performance in healthy and brain-injured individuals such as increased naming accuracy. However, at present, it is not known what effect tDCS has on higher-level language skills like discourse production (i.e. story telling, giving instructions) in healthy, older speakers. Therefore, the aim of this study is to investigate in healthy older adults, the effect of tDCS on discourse production as well as the ideal tDCS electrode placement for improving language at the discourse level. It is hypothesised that tDCS will result in greater language changes and improvements during discourse production compared to no stimulation.

NCT ID: NCT04260763 Completed - Clinical trials for Schizophrenia; Psychosis

Evaluating a Novel Mobile App for Social Cognition in Psychosis

Start date: August 30, 2018
Phase: N/A
Study type: Interventional

To develop, and then evaluate a mobile phone app to deliver therapy homework activities between group sessions (social cognition intervention) in individuals with psychosis. The investigators are interested in whether offering homework via an app is a) feasible, and b) acceptable. The investigators will also assess whether there is an initial indication that offering homework via the app improves outcomes following the group therapy.

NCT ID: NCT04260568 Completed - Vestibular Disease Clinical Trials

How do Individuals Respond to a Diagnosis of 3PD

Start date: November 8, 2019
Phase:
Study type: Observational

No studies have explored how patients with chronic dizziness react to a diagnosis of Persistent Postural Perceptual Dizziness (3PD) and their beliefs and representations of the diagnostic label. Investigating the experience of diagnostic labelling from the perspective of patients will allow clinicians to recognise whether this is a helpful term to adopt and ways to improve the clinical consultation. This is a qualitative study that will consist of semi-structured interviews with people with a new diagnosis of 3PD. The main objective of the study is to explore how patients react to this diagnostic label, what they understand about their diagnosis and how their own meanings affect their expectations and illness perceptions. Between 12-15 patients will be recruited from the balance clinic at Guy's Hospital, London, UK. The qualitative data will be analysed using thematic analysis which will draw on pragmatic interpretive descriptive methodology.

NCT ID: NCT04259437 Completed - Clinical trials for Gastro-Intestinal Tolerance

Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition

Start date: March 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the GI tolerance, palatability and compliance to a high protein energy-dense oral nutrition supplement in adult patients with or at risk of malnutrition.

NCT ID: NCT04257669 Completed - Iron Status Clinical Trials

The Relationship Between Iron Status, Cognitive Performance, Subjective Mood and Fatigue in Women of Reproductive Age.

Start date: May 19, 2017
Phase:
Study type: Observational

Iron deficiency is the most prevalent nutritional deficiency worldwide with one in four estimated to be affected by iron deficiency anaemia. Women of reproductive age are at greatest risk for iron deficiency and anaemia due to iron losses during menstruation and childbirth as well as the increased need for iron throughout pregnancy. However, iron deficiency without anaemia is at least twice as common as iron deficiency anaemia with females aged 11-49 at the biggest risk of all. Despite this, it is commonly left undiagnosed. Those who are iron deficient non-anaemic can still suffer from the same common consequences of iron deficiency anaemia; these include unexplained fatigue, mood changes and decreased cognitive performance. Previous studies have found a significant relationship between iron status and cognitive performance in anaemic women. However, studies assessing cognition, mood and fatigue in women of varying iron status including those who are iron deficient nonanaemic are lacking. The most recent observational study of this kind found that better iron status was associated with better sustained attention but worse working memory. However, iron deficient anaemic females were not included in this observation. This study will extend upon this in order to determine any differences between non-anaemic iron deficiency and iron deficiency anaemia. The aims of this study are to improve knowledge concerning women's health and to determine whether there is a relationship between iron status, cognitive performance, subjective mood and fatigue in women of reproductive age (18-49 years).

NCT ID: NCT04256044 Completed - Asthma Clinical Trials

Analysis of Peripheral Blood ILC2s and Th2 Cells in Response to ANB020

Start date: November 23, 2017
Phase:
Study type: Observational

This exploratory laboratory only study will assess alterations in immune cells in blood samples that may be responsive to an inflammatory mediator in asthma called IL-33 (Innate lymphoid type 2 cells, basophils and Th2 cells) in response to treatment with ANB020/placebo (a drug that targets IL-33, in the linked clinical trial ANB020-004). The study will involve additional 10ml blood draws on scheduled study visits in the ANB020-004 clinical trial at baseline, 1 week, 5 weeks, 18 weeks (4 visits total). Total number of subjects is 24 at the same 3 participating UK sites as the main linked clinical trial ANB020-004. Blood samples will be sent on the same day to a flow cytometry laboratory at the NIHR Leicester Biomedical Research Centre (BRC) - Respiratory. A dedicated post doctoral, trained laboratory scientist will analyse the blood samples for the required cell types using a technique called flow cytometry - this technique identifies cell surface and intercellular markers, that together provide a unique cell identity. The experiments will be supervised by a senior research scientist and flow cytometrist Professor Dave Cousins, at the University of Leicester and results of the experiments will be fed back to AnaptysBio (the linked clinical trial Sponsor). Professor Salman Siddiqui at the University of Leicester will oversee the clinical conduct of this laboratory study and act as the Chief Investigator. Professor Siddiqui is also the local site lead Principal Investigator at Leicester for the linked ANB020-004 clinical trial described below. The linked study (ANB020-004) is a Double-blind Placebo-Controlled Proof of Concept Study to Investigate ANB020 (a drug that targets an inflammatory mediator called IL-33) Activity in Adult Patients with Severe Eosinophilic Asthma. The expected duration of the study is up to 141 days. Screening period of 7-14 days and treatment and follow-up period of 127 days.

NCT ID: NCT04256005 Completed - PreDiabetes Clinical Trials

Optimisation of Exercise Intensity During High-Intensity Interval Training for Glucose Control in Prediabetes

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The aim of the current study is to identify the optimal exercise intensity of the high-intensity phase during a bout of High-Intensity Interval Training (HIIT) to increase glucose clearance in a prediabetic population. The study is a within-subjects randomised crossover design with participants attending the laboratory on seven occasions over a two week period. The first visit will be to perform medical screening and to obtain informed consent. The second visit will be to collect baseline measures, select meal plans, to collect an activity tracker and to complete a ramped exercise test to establish exercise intensity thresholds. The third visit will be to fit an interstitial glucose sensor and to collect the standardised meals which will be provided to each participant. Visits four, five, and six will be the experimental trials. The seventh visit will be to remove the interstitial glucose sensor and return the activity tracker.

NCT ID: NCT04255654 Completed - Food Deprivation Clinical Trials

A Brief Intervention for Food Insecurity in Dietetic Practice

BIFI
Start date: August 28, 2019
Phase: N/A
Study type: Interventional

1 in 10 people in the UK cannot afford enough nutritious food to eat, to help them and their family stay healthy. We aim to find out what it would be like for both dietitians and their clients to be asked, routinely in a dietetic appointment, about having enough food to eat. Your dietitian will ask you 2 questions about your access to food and, if you want, they will discuss some options which might be helpful for you if your access to food is limited. Some of the discussions that take place (regarding the intervention only) will be audio recorded with your consent to check they are being done correctly. If options which might be helpful for you to get more access to food were required you will then be asked to take part in a telephone interview, which will be audio recorded and will involve discussing your experience of the intervention and what you did with the information provided. After this telephone interview, this will be the end of the study for you.